Aaron Richterman, MD, MPH is an Assistant Professor of Medicine in the Division of Infectious Diseases at the Hospital of the University of Pennsylvania. He uses multiple research methodologies to evaluate the relationships between poverty, food security, and individual and population health outcomes (in particular those related to infectious diseases). He is interested in both non-experimental approaches to assessing the effects of poverty reduction and social protection programs on health outcomes, and in conducting hypothesis-driven research to design and evaluate innovative economic interventions to enable health behaviors and improve clinical outcomes. His work spans high- and low-income settings, with a focus on public-academic and community-academic partnerships. He has clinical expertise in HIV, and sees patients living with HIV in clinic weekly. Dr. Richterman earned his MD at the University of Pennsylvania’s Perelman School of Medicine and his MPH at the Harvard T.H. Chan School of Public Health.
Senior Fellow
Aaron Richterman, MD, MPH
- Assistant Professor, Infectious Disease, Perelman School of Medicine
- Assistant Professor, Medical Ethics and Health Policy, Perelman School of Medicine
Related Content
Cash Transfer Programs Are Growing More Common in the U.S. As Studies Show They Improve People’s Health
But the Public Remains Skeptical and Policymakers Have Been Leery to Launch Big Efforts
In The Media WHYY
Food Insufficiency Rates Jump Among Snap Recipients After Expanded Pandemic Benefits End, Penn Study Finds
Interview
Cash Payments Linked to Improved HIV Prevention and Outcomes
Study of 42 Countries Supports Antipoverty Programs for HIV Control
In The Media NBC News
Vaccinated People Are Less Likely To Spread COVID, New Research Finds
Interview
In The Media CBC News
Canada Was Already Desperately Short of Nurses Before COVID-19. Now Nurses Say They’re Hanging On by a Thread
Interview
In The Media Philadelphia Inquirer
Delta Variant’s Outdoor Transmission is Still Unclear. Here’s How Philly Experts are Thinking About COVID-19 Risk.
Interview